<DOC>
	<DOCNO>NCT00080873</DOCNO>
	<brief_summary>RATIONALE : Traumeel® S ( mouth rinse ) may effective prevent decrease severity oral mucositis cause chemotherapy young patient undergoing stem cell transplantation . PURPOSE : This randomized clinical trial study well Traumeel® S work prevent treat mucositis young patient receive chemotherapy without total-body irradiation undergo stem cell transplantation .</brief_summary>
	<brief_title>Traumeel® S Preventing Treating Mucositis Young Patients Undergoing Stem Cell Transplantation</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy Traumeel® S v placebo reduce severity duration chemotherapy-induced ( without total body irradiation ) mucositis pediatric patient undergo hematopoietic stem cell transplantation . - Determine safety drug patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord treatment total body irradiation condition chemotherapy ( yes v ) , type transplantation ( autologous v allogeneic ) , participate institution ( COG v foreign ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral Traumeel® S mouth rinse 5 time daily begin day -1 transplantation . - Arm II : Patients receive oral placebo mouth rinse 5 time daily begin day -1 transplantation . In arm , treatment continue day 20 post-transplantation OR mucositis resolve Walsh score ≤ 1 2 consecutive day . Patients follow day 100 post-transplantation . PROJECTED ACCRUAL : A total 180 patient ( 90 per treatment arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Planned treatment allogeneic autologous hematopoietic stem cell transplantation Conditioning chemotherapy regimen transplantation must myeloablative Source stem cell follow : Bone marrow Placental cord Cytokinemobilized peripheral blood Availability 1 follow donor type : HLAmatched sibling parent Related donor mismatch single HLA locus ( class I II ) Unrelated marrow peripheral blood stem cell donor Unrelated umbilical cord blood HLAmatched mismatch ( class I ) donor PATIENT CHARACTERISTICS : Age 3 25 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No known allergy Echinacea Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy See Disease Characteristics Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other No concurrent oral vancomycin paste No concurrent oral glutamine supplementation No mouth care oral medication within 30 minute administration study drug No concurrent treatment prevent mouth sore</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>oral complication</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>recurrent neuroblastoma</keyword>
</DOC>